Literature DB >> 11461086

The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer.

T Kajita1, Y Ohta, K Kimura, M Tamura, Y Tanaka, Y Tsunezuka, M Oda, T Sasaki, G Watanabe.   

Abstract

Expression of vascular endothelial growth factor (VEGF)-C and that of its receptors were assessed in non-small cell lung cancer. Immunohistochemistry revealed positive VEGF-C expression in 38.7% (24/62) of the patients studied. A significant positive correlation was found between VEGF-C in cancer cells and VEGF receptor-3 (VEGFR-3) in vascular endothelial cells, but not between VEGF-C in cancer cells and VEGFR-2 in endothelial cells. In this cohort of lung cancer patients, VEGF-C expression was significantly associated with lymph node metastasis, lymphatic vessel invasion, and worse outcomes after the operation. Although the independent prognostic impact of VEGF-C and VEGFR-3 was not clear, VEGFR-2 expression in endothelial cells retained the independency as the prognostic indicator. In light of these findings, we conclude that VEGF-C plays an important role in lymphatic invasion/metastasis and tumour progression in non-small cell lung cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461086      PMCID: PMC2364042          DOI: 10.1054/bjoc.2001.1882

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.

Authors:  T Niki; S Iba; M Tokunou; T Yamada; Y Matsuno; S Hirohashi
Journal:  Clin Cancer Res       Date:  2000-06       Impact factor: 12.531

2.  Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis.

Authors:  H Yonekura; S Sakurai; X Liu; H Migita; H Wang; S Yamagishi; M Nomura; M J Abedin; H Unoki; Y Yamamoto; H Yamamoto
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

3.  Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.

Authors:  S J Mandriota; L Jussila; M Jeltsch; A Compagni; D Baetens; R Prevo; S Banerji; J Huarte; R Montesano; D G Jackson; L Orci; K Alitalo; G Christofori; M S Pepper
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

4.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.

Authors:  M Skobe; T Hawighorst; D G Jackson; R Prevo; L Janes; P Velasco; L Riccardi; K Alitalo; K Claffey; M Detmar
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

5.  Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

Authors:  C A Boocock; D S Charnock-Jones; A M Sharkey; J McLaren; P J Barker; K A Wright; P R Twentyman; S K Smith
Journal:  J Natl Cancer Inst       Date:  1995-04-05       Impact factor: 13.506

6.  Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors.

Authors:  H Gitay-Goren; R Halaban; G Neufeld
Journal:  Biochem Biophys Res Commun       Date:  1993-02-15       Impact factor: 3.575

7.  FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines.

Authors:  K Pajusola; O Aprelikova; J Korhonen; A Kaipainen; L Pertovaara; R Alitalo; K Alitalo
Journal:  Cancer Res       Date:  1992-10-15       Impact factor: 12.701

8.  Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.

Authors:  J Waltenberger; L Claesson-Welsh; A Siegbahn; M Shibuya; C H Heldin
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

9.  VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.

Authors:  Y Ohta; V Shridhar; R K Bright; G P Kalemkerian; W Du; M Carbone; Y Watanabe; H I Pass
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

10.  Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues.

Authors:  K Akagi; Y Ikeda; M Miyazaki; T Abe; J Kinoshita; Y Maehara; K Sugimachi
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

View more
  37 in total

Review 1.  Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancer.

Authors:  Seiji Yano; Yuka Matsumori; Kenji Ikuta; Hirokazu Ogino; Tamir Doljinsuren; Saburo Sone
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

Review 2.  Molecular pathways of lymphangiogenesis and lymph node metastasis in head and neck cancer.

Authors:  A D Karatzanis; E Koudounarakis; I Papadakis; G Velegrakis
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-10-21       Impact factor: 2.503

Review 3.  Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.

Authors:  C-Q Zhu; W Shih; C-H Ling; M-S Tsao
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

4.  Clinical significance of VEGF-C and VEGFR-3 expression in non-small cell lung cancer.

Authors:  Jun Li; Mei Hong; Tiecheng Pan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

5.  Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.

Authors:  Shusaku Ohira; Motoko Sasaki; Kenichi Harada; Yasunori Sato; Yoh Zen; Kumiko Isse; Kazuto Kozaka; Akira Ishikawa; Koji Oda; Yuji Nimura; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

Review 6.  Lymphangiogenesis, lymphatic systemomics, and cancer: context, advances and unanswered questions.

Authors:  Michael T Dellinger; Marlys H Witte
Journal:  Clin Exp Metastasis       Date:  2018-05-28       Impact factor: 5.150

7.  Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer.

Authors:  Yutaka Yonemura; Yoshio Endo; Kayoko Tabata; Taiichi Kawamura; Hyo-Yung Yun; Etsurou Bandou; Takuma Sasaki; Masahiro Miura
Journal:  Int J Clin Oncol       Date:  2005-10       Impact factor: 3.402

8.  VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus.

Authors:  Christian Möbius; José Freire; Ingrid Becker; Marcus Feith; Björn L D M Brücher; Michael Hennig; J Rüdiger Siewert; Hubert J Stein
Journal:  World J Surg       Date:  2007-09       Impact factor: 3.352

Review 9.  Molecular testing in lung cancer in the era of precision medicine.

Authors:  Helmut H Popper; Ales Ryska; József Tímár; Wlodzimierz Olszewski
Journal:  Transl Lung Cancer Res       Date:  2014-10

10.  Low density lipoprotein receptor mediates anti-VEGF effect of lymphocyte T-derived microparticles in Lewis lung carcinoma cells.

Authors:  Chun Yang; Carmen Gagnon; Xin Hou; Pierre Hardy
Journal:  Cancer Biol Ther       Date:  2010-09-30       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.